NIJMEGEN, The Netherlands--(BUSINESS WIRE)--Aiosyn, a software company that develops AI-powered pathology software, has announced the integration of its AI-powered automated quality control (QC) ...

NIJMEGEN, Netherlands--(BUSINESS WIRE)--Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, announced the introduction of its ...

OREM, UT, AND NIJMEGEN, NETHERLANDS, UT, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Techcyte, a leader in digital pathology and Aiosyn, a leading developer ...

NIJMEGEN, Netherlands–(BUSINESS WIRE)–Aiosyn, a medical software company specializing in AI-powered pathology solutions, has announced the release of an AI kidney suite designed to advance research in ...

Joint solution enables Aiosyn’s AI algorithms to run at the edge within Pramana scanners, allowing for rapid diagnosis and radically improved operational workflow NIJMEGEN, Netherlands & CAMBRIDGE, ...

Breast cancer is the most common cancer among women, with 2.3 million new cases diagnosed annually worldwide¹, including 604,900 in the WHO Europe region in 2022². Despite significant advancements ...

NIJMEGEN, Netherlands--(BUSINESS WIRE)--Aiosyn, a software company that develops AI-powered pathology solutions, has announced the latest advancement in their automated quality control (QC) algorithm.

Aiosyn, a medical software company specializing in AI-powered pathology solutions, has announced the release of an AI kidney suite designed to advance research in the field of renal disease.

Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a EUR 1.300.000 EFRO-OOST grant alongside Radboud university medical center and Pathologie-DNA to ...

Joint solution enables Aiosyn's AI algorithms to run at the edge within Pramana scanners, allowing for rapid diagnosis and radically improved operational workflow Aiosyn, a pioneering pathology ...